ReDREAM (Resistant Depression Response to Esketamine Assessing Metabolomics) Project: Untargeted metabolomics to identify biomarkers of treatment response to intranasal esketamine in individuals with Treatment-Resistant Depression

Progetto di ricerca: 

ReDREAM (Resistant Depression Response to Esketamine Assessing Metabolomics) Project: Untargeted metabolomics to identify biomarkers of treatment response to intranasal esketamine in individuals with Treatment-Resistant Depression

Responsabile scientifico: 

UMBERTO ALBERT

Data inizio: 

27/09/2023

Data fine: 

20/10/2025

Finanziatore: 

MINISTERO DELL'UNIVERSITA' E DELLA RICERCA

Acronimo: 

ReDREAM

Persona	Ruolo
Prof. Umberto Albert	Progetti di ricerca - Responsabile scientifico;

Ultimo aggiornamento: 06-12-2024 - 20:30